Aarti Pharmalabs Ltd

Thu 22/10/2026,15:59:58 | NSE : AARTIPHARM

₹828.80-14.45 (-1.71%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 840.00

Previous Close

₹ 843.25

Volume

414639

Mkt Cap ( ₹ Cr)

₹ 7515.54

High

₹ 844.00

Low

₹ 821.00

52 Week High

₹ 1002.40

52 Week Low

₹ 585.00

Book Value Per Share

₹ 241.88

Dividend Yield

0.00

Face Value

₹ 5.00

What's Your Call?

Collective community sentiment on Aarti Pharmalabs Ltd

Your Vote -

Buy

92.31%

Hold

0.00%

Sell

7.69%

92.31%

13 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Aarti Pharmalabs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Oct 2026, 3:57PM This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Thursday, October 28, 2026, at 3:30 p.m. (IS

  • Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    17 Oct 2026, 2:30PM As of September 2026, 39.66% is owned by Promoters and 60.34% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 39.49% and

  • Aarti Pharmalabs - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The S

    9 Oct 2026, 4:31PM Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and

  • Aarti Pharmalabs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Oct 2026, 12:54PM Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Aarti Pharmalabs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Oct 2026, 12:49PM Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026.

  • Aarti Pharmalabs - General Updates

    30 Sep 2026, 5:44PM Aarti Pharmalabs Limited has informed the Exchange about Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)

  • Aarti Pharmalabs - Updates

    30 Sep 2026, 11:05AM Aarti Pharmalabs Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI Listing Regulations- Reconstitution of Committee

  • Aarti Pharmalabs - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    30 Sep 2026, 5:38PM Please find enclosed

  • Aarti Pharmalabs - Intimation Under Regulation 30 Of SEBI Listing Regulations

    30 Sep 2026, 11:01AM Please find enclosed

  • Aarti Pharmalabs - Trading Window

    28 Sep 2026, 10:58AM Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Aarti Pharmalabs - Updates

    23 Sep 2026, 6:53PM Aarti Pharmalabs Limited has informed the Exchange regarding 'Updates on Change in Directorate'.

  • Aarti Pharmalabs - Updates On Change In Directorate

    23 Sep 2026, 6:51PM Please find enclosed

  • Aarti Pharmalabs - Shareholders meeting

    23 Sep 2026, 6:27PM Aarti Pharmalabs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the comp

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation

    22 Sep 2026, 6:20PM Investor Presentation made at the 7th Annual General Meeting

  • Aarti Pharmalabs - Updates

    22 Sep 2026, 6:16PM Aarti Pharmalabs Limited has informed the Exchange regarding 'Presentation made to the shareholders at 7th AGM'.

  • Aarti Pharmalabs - Shareholders meeting

    22 Sep 2026, 5:31PM Aarti Pharmalabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Outcome of AGM

    22 Sep 2026, 5:26PM Proceedings of the 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2026, 6:24PM Scrutinizers Report and Voting Result of 7th Annual General Meeting

  • Aarti Pharmalabs - General Updates

    2 Sep 2026, 8:42PM Aarti Pharmalabs Limited has informed the Exchange about General Updates

  • Aarti Pharmalabs - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    2 Sep 2026, 8:30PM Please find enclosed

  • Aarti Pharmalabs - Resignation of Director/KMP/SMP

    31 Aug 2026, 7:57PM Aarti Pharmalabs Limited has informed the Exchange about Resignation of Director/KMP/SMP

  • Aarti Pharmalabs - Change in Management

    31 Aug 2026, 7:47PM Aarti Pharmalabs Limited has informed the Exchange about change in Management

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Change in Management

    31 Aug 2026, 7:44PM Please find enclosed

  • Aarti Pharmalabs - Copy of Newspaper Publication

    30 Aug 2026, 12:43PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Updates

    29 Aug 2026, 7:04PM Aarti Pharmalabs Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.

  • Aarti Pharmalabs - Shareholders meeting

    29 Aug 2026, 3:21PM Aarti Pharmalabs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026

  • Aarti Pharmalabs - Business Responsibility and Sustainability Reporting (BRSR)

    29 Aug 2026, 3:25PM Please find enclosed BRSR for FY 2025-26

  • Aarti Pharmalabs - Notice Of 7Th Annual General Meeting Of The Company

    29 Aug 2026, 3:17PM Please find enclosed

  • Aarti Pharmalabs - Reg. 34 (1) Annual Report.

    29 Aug 2026, 3:01PM Please find enclosed, Annual Report for FY 2025-26

  • Aarti Pharmalabs Q1 net profit up 39.22% at Rs 71.31 cr

    22 Aug 2026, 7:50PM The company reported standalone net profit of Rs 71.31 crore for the quarter ended June 30, 2026 as compared to Rs 51.22 crore in the same period last

  • Aarti Pharmalabs has declared 40% Final dividend for the financial year March 2026

    21 Aug 2026, 12:31PM Aarti Pharmalabs Ltd. on Monday, 25 May 2026, has announced Final dividend of 40 percent on Equity Share, to its shareholders holding shares on the re

  • Aarti Pharmalabs - Copy of Newspaper Publication

    18 Aug 2026, 3:07PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Record Date

    17 Aug 2026, 5:26PM Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026.

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Aug 2026, 4:31PM Aarti Pharmalabs Limited has informed the Exchange about Transcript

  • Aarti Pharmalabs - Record Date For Dividend For FY 2025-26

    17 Aug 2026, 5:24PM Disclosure as enclosed

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    17 Aug 2026, 4:28PM Q1 FY 27 Earnings Call Transcript

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Aug 2026, 9:40PM Aarti Pharmalabs Limited has informed the Exchange about Link of Recording

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    10 Aug 2026, 9:39PM Audio Recording of Conference Call for Investor and Analysts

  • Aarti Pharmalabs - Investor Presentation

    10 Aug 2026, 1:19PM Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation

    10 Aug 2026, 1:17PM Q1 FY 2027 Investor Presentation

  • Aarti Pharmalabs - Copy of Newspaper Publication

    9 Aug 2026, 1:05PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Change in Director(s)

    7 Aug 2026, 9:02PM Aarti Pharmalabs Limited has informed the Exchange regarding Change in Director(s) of the company.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Change in Directorate

    7 Aug 2026, 9:01PM As enclosed

  • Aarti Pharmalabs - Updates

    7 Aug 2026, 8:28PM Aarti Pharmalabs Limited has informed the Exchange regarding 'Capacity Addition'.

  • Aarti Pharmalabs - Approved Capacity Addition For Development Of Intermediate Block

    7 Aug 2026, 8:16PM Disclosure as enclosed

  • Aarti Pharmalabs - Change in Director(s)

    7 Aug 2026, 8:06PM Aarti Pharmalabs Limited has informed the Exchange regarding Change in Director(s) of the company.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Change in Directorate

    7 Aug 2026, 8:04PM Disclosure as enclosed

  • Aarti Pharmalabs - Outcome of Board Meeting

    7 Aug 2026, 8:00PM Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Aarti Pharmalabs - Approval Of Unaudited Financial Results (Standalone And Consolidated)For The Quarter Ended June 30, 2026

    7 Aug 2026, 7:57PM Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter Ended June 30, 2026

  • Aarti Pharmalabs - Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026.

    7 Aug 2026, 7:48PM Outcome of Board Meeting held on August 07, 2026.

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Aug 2026, 11:48AM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Aug 2026, 11:39AM This is to inform you that the Earnings Conference Call for investors and analysts has been scheduled for Monday, August 10, 2026, at 4:00 p.m. (IST)

  • Aarti Pharmalabs - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.

    28 Jul 2026, 10:48AM Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Aarti Pharmalabs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 2667.985 2238.7261 1872.2571 1645.2909 1608.9004
Liabilities 2667.985 2238.7261 1872.2571 1645.2909 1608.9004
Equity 45.3289 45.3173 45.313 45.313 45.563
Gross Profit 372.9102 426.5433 346.1585 308.3352 179.7858
Net Profit 176.202 257.3488 200.6454 171.7268 106.7261
Cash From Operating Activities 257.2577 340.0057 183.6944 228.6894 -64.8426
NPM(%) 9.8 14.52 13.35 11.36 11.34
Revenue 1797.5516 1771.3518 1502.1319 1511.2478 941.021
Expenses 1424.6414 1344.8085 1155.9734 1202.9126 761.2352
ROE(%) 8.03 11.73 9.14 7.82 4.86

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
15 Sep 2026 2 40 0 732.45
16 Feb 2026 1.5 30 0 794.75
15 Sep 2025 2.5 50 0 799.45
14 Feb 2025 2.5 50 0 636.3
31 Jul 2024 1 20 0 520.05
2 40 0 557.85

Peers

Other companies within the same industry or sector that are comparable to Aarti Pharmalabs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1498.70 -1.12 13.18 752.71 1071.07 0.47
Sharda Cropchem Ltd 659.60 -2.55 9.50 7479.73 754.66 2.27
Amines and Plasticizers Ltd 147.55 -3.66 21.05 4561.43 331.99 0.34
Indogulf Cropsciences Ltd 60.27 2.57 9.88 5241.59 63.31 0.00

Company Info

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd. 2025 -Aarti Pharmalabs Ltd. Credit Rating Upgraded to CRISIL AA-/Stable, Reflecting Strong Financial Health and Business Prospects. -Aarti Pharmalabs Earns EcoVadis Gold Rating, Among Top 5% Globally for Sustainability. -Aarti Pharmalabs Ltd. Achieves Key Sustainability Milestone with Approval of GHG Emission Reduction Targets by Science Based Target initiative (SBTi).

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd. 2025 -Aarti Pharmalabs Ltd. Credit Rating Upgraded to CRISIL AA-/Stable, Reflecting Strong Financial Health and Business Prospects. -Aarti Pharmalabs Earns EcoVadis Gold Rating, Among Top 5% Globally for Sustainability. -Aarti Pharmalabs Ltd. Achieves Key Sustainability Milestone with Approval of GHG Emission Reduction Targets by Science Based Target initiative (SBTi).

Parent Organisation

Aarti Pharmalabs Ltd.

Founded

22/11/2019

Managing Director

Mr.Narendra J Salvi

NSE Symbol

AARTIPHARMEQ

FAQ